Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 26, 2021	Sep. 25, 2020
Current assets:
Cash and cash equivalents	$ 1,104,570	$ 1,071,876
Restricted cash	8,926	8,103
Short-term investments	58,582	46,948
Accounts receivable, net of allowance for credit losses of $11,671 and $15,908	283,505	180,340
Contract assets, net of allowance for credit losses of $189 and $0	233,379	161,357
Inventories, net	14,881	25,550
Prepaid expenses and other current assets	47,305	53,022
Total current assets	1,751,148	1,547,196
Long-term investments	42,188	52,149
Property, plant, and equipment, net	542,702	541,963
Operating lease right-of-use assets	71,976	76,515
Intangible assets, net	136,944	152,431
Goodwill	338,235	336,945
Other non-current assets	87,546	91,245
Deferred taxes	135,551	118,881
Total assets	3,106,290	2,917,325
Current liabilities:
Accounts payable	8,385	12,617
Accrued liabilities	254,163	219,974
Income taxes payable	11,087	3,260
Contract liabilities	20,029	15,436
Operating lease liabilities	15,313	15,822
Total current liabilities	308,977	267,109
Non-current contract liabilities	23,369	24,342
Non-current operating lease liabilities	61,165	65,315
Other non-current liabilities	118,559	122,154
Total liabilities	512,070	478,920
Stockholders’ equity:
Retained earnings	2,591,870	2,443,138
Accumulated other comprehensive loss	(4,039)	(10,594)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,587,931	2,432,643
Controlling interest	6,289	5,762
Total stockholders’ equity	2,594,220	2,438,405
Total liabilities and stockholders’ equity	3,106,290	2,917,325
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 65,206,586 shares issued and outstanding at March 26, 2021 and 64,167,725 at September 25, 2020
Stockholders’ equity:
Common stock	59	58
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,107,779 shares issued and outstanding at March 26, 2021 and 36,128,720 at September 25, 2020
Stockholders’ equity:
Common stock	$ 41	$ 41